重组刚地弓形虫致密颗粒蛋白15对C57BL/6小鼠弓形虫病的保护效力
本研究在C57BL/6小鼠模型中评估重组刚地弓形虫致密颗粒蛋白15(rGRA15)的免疫刺激与保护效力。rGRA15免疫可诱导特异性抗体和IFN-γ产生,显著提高Pru(II型)株攻击后小鼠生存率并降低虫负荷,但对GRA15缺陷Pru株或RH(I型)株攻击的小鼠全部死亡。
要点
- rGRA15免疫诱导抗TgGRA15特异性IgG、IgG1和IgG2c抗体产生。
- rGRA15免疫显著提高Pru(II型)株攻击后小鼠生存率并降低虫负荷。
- 对GRA15缺陷Pru株或RH(I型)株攻击,所有免疫小鼠均死亡。
核心结论
- rGRA15可激发体液和细胞免疫应答以控制感染,GRA15(II)依赖性免疫在抵抗II型弓形虫攻击感染中起关键作用。
- 本研究首次报道GRA15(II)可作为抗弓形虫感染的重组疫苗抗原。
研究设计与样本
- 在C57BL/6小鼠模型中评估重组GRA15(II)(rGRA15)的免疫刺激和保护效力。
主要发现
- 体外实验中,rGRA15处理增加小鼠腹腔巨噬细胞IL-12p40的产生。
- rGRA15免疫小鼠诱导产生抗TgGRA15特异性IgG、IgG1和IgG2c抗体。
- 用同一抗原致敏的脾细胞强烈促进脾细胞增殖和IFN-γ产生。
- rGRA15免疫显著提高Pru(II型)株攻击小鼠的生存率并大幅降低虫负荷。
- 所有免疫小鼠在GRA15缺陷Pru株或RH(I型)株攻击后均死亡。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Toxoplasma gondii is a pervasive protozoan parasite that is responsible for significant zoonoses. A wide array of vaccines using different effector molecules of T. gondii have been studied worldwide to control toxoplasmosis. None of the existing vaccines are sufficiently effective to confer protective immunity. Among the different Toxoplasma-derived effector molecules, T. gondii dense granule protein 15 from the type II strain (GRA15 (II)) was recently characterized as an immunomodulatory molecule that induced host immunity via NF-κB. Therefore, we assessed the immunostimulatory and protective efficacy of recombinant GRA15 (II) (rGRA15) against T. gondii infection in a C57BL/6 mouse model. We observed that rGRA15 treatment increased the production of IL-12p40 from mouse peritoneal macrophages in vitro. Immunization of mice with rGRA15 induced the production of anti-TgGRA15-specific IgG, IgG1 and IgG2c antibodies. The rGRA15-sensitized spleen cells from mice inoculated with the same antigen strongly promoted spleen cell proliferation and IFN-γ production. Immunization with rGRA15 significantly enhanced the survival rate of mice and dramatically decreased parasite burden in mice challenged with the Pru (type II) strain. These results suggested that rGRA15 triggered humoral and cellular immune responses to control infection. However, all of the immunized mice died when challenged with the GRA15-deficient Pru strain or the RH (type I) strain. These results suggest that GRA15 (II)-dependent immunity plays a crucial role in protection against challenge infection with the type II strain of T. gondii. This study is the first report to show GRA15 (II) as a recombinant vaccine antigen against Toxoplasma infection.
引用
- Hasan T, Shimoda N, Nakamura S, et al. Protective efficacy of recombinant Toxoplasma gondii dense granule protein 15 against toxoplasmosis in C57BL/6 mice. Vaccine. 2024. PMID: 38429153. doi:10.1016/j.vaccine.2024.02.062
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。